Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be proved.
Ann Oncol
; 22(4): 988, 2011 Apr.
Article
in En
| MEDLINE
| ID: mdl-21345940
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Sarcoma
/
Antineoplastic Agents, Alkylating
/
Tetrahydroisoquinolines
/
Dioxoles
Type of study:
Health_economic_evaluation
Limits:
Humans
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2011
Document type:
Article